Literature DB >> 15459676

The role of the medicinal chemist in drug discovery--then and now.

Joseph G Lombardino1, John A Lowe.   

Abstract

The role of the medicinal chemist in drug discovery has undergone major changes in the past 25 years, mainly because of the introduction of technologies such as combinatorial chemistry and structure-based drug design. As medicinal chemists with more than 50 years of combined experience spanning the past four decades, we discuss this changing role using examples from our own and others' experience. This historical perspective could provide insights in to how to improve the current model for drug discovery by helping the medicinal chemist regain the creative role that contributed to past successes.

Mesh:

Substances:

Year:  2004        PMID: 15459676     DOI: 10.1038/nrd1523

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  39 in total

1.  Serendipity in anticancer drug discovery.

Authors:  Emily Hargrave-Thomas; Bo Yu; Jóhannes Reynisson
Journal:  World J Clin Oncol       Date:  2012-01-10

Review 2.  Medicinal chemistry and the pharmacy curriculum.

Authors:  M O Faruk Khan; Michael J Deimling; Ashok Philip
Journal:  Am J Pharm Educ       Date:  2011-10-10       Impact factor: 2.047

Review 3.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

4.  The flow synthesis of heterocycles for natural product and medicinal chemistry applications.

Authors:  Marcus Baumann; Ian R Baxendale; Steven V Ley
Journal:  Mol Divers       Date:  2010-10-20       Impact factor: 2.943

5.  Academic-Industrial Collaboration: Toward the Consilience of Two Solitudes.

Authors:  Stephen Hanessian
Journal:  ACS Med Chem Lett       Date:  2015-12-22       Impact factor: 4.345

Review 6.  Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery.

Authors:  Tom L Blundell; Bancinyane L Sibanda; Rinaldo Wander Montalvão; Suzanne Brewerton; Vijayalakshmi Chelliah; Catherine L Worth; Nicholas J Harmer; Owen Davies; David Burke
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-03-29       Impact factor: 6.237

7.  Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli.

Authors:  Effendi Leonard; Kok-Hong Lim; Phan-Nee Saw; Mattheos A G Koffas
Journal:  Appl Environ Microbiol       Date:  2007-04-27       Impact factor: 4.792

Review 8.  Fragment-based QSAR: perspectives in drug design.

Authors:  Lívia B Salum; Adriano D Andricopulo
Journal:  Mol Divers       Date:  2009-01-31       Impact factor: 2.943

9.  Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties.

Authors:  Wasfy M Obeidat; Al-Sayed A Sallam
Journal:  AAPS PharmSciTech       Date:  2014-01-09       Impact factor: 3.246

10.  Analysis of structure-Caco-2 permeability relationships using a property landscape approach.

Authors:  Yareli Rojas-Aguirre; José L Medina-Franco
Journal:  Mol Divers       Date:  2014-04-08       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.